Dmitry Kobyzev - Net Worth and Insider Trading

Dmitry Kobyzev Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Dmitry Kobyzev owns 1 companies in total, including Protara Therapeutics Inc (TARA) .

Click here to see the complete history of Dmitry Kobyzev’s form 4 insider trades.

Insider Ownership Summary of Dmitry Kobyzev

Ticker	Company	Transaction Date	Type of Owner
TARA	Protara Therapeutics Inc	2014-10-21	director & 10 percent owner

Dmitry Kobyzev Trading Performance

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Dmitry Kobyzev Ownership Network

Ownership Network List of Dmitry Kobyzev

No Data

Ownership Network Relation of Dmitry Kobyzev

Dmitry Kobyzev Owned Company Details

What does Protara Therapeutics Inc do?

Who are the key executives at Protara Therapeutics Inc?

Dmitry Kobyzev is the director & 10 percent owner of Protara Therapeutics Inc. Other key executives at Protara Therapeutics Inc include Sr. Vice President & Research Jacqueline Zummo , 10 percent owner Opaleye Management Inc. , and Chief Financial Officer Patrick Fabbio .

Protara Therapeutics Inc (TARA) Insider Trades Summary

Over the past 18 months, Dmitry Kobyzev made no insider transaction in Protara Therapeutics Inc (TARA). Other recent insider transactions involving Protara Therapeutics Inc (TARA) include a net sale of 703,460 shares made by Opaleye Management Inc. , a net purchase of 40,000 shares made by Richard S Levy , and a net sale of 21,224 shares made by Jacqueline Zummo .

In summary, during the past 3 months, insiders sold 0 shares of Protara Therapeutics Inc (TARA) in total and bought 40,000 shares, with a net purchase of 40,000 shares. During the past 18 months, 724,684 shares of Protara Therapeutics Inc (TARA) were sold and 40,000 shares were bought by its insiders, resulting in a net sale of 684,684 shares.

Protara Therapeutics Inc (TARA)'s detailed insider trading history can be found in Insider Trading Tracker table.

Protara Therapeutics Inc Insider Transactions

No Available Data

Dmitry Kobyzev Mailing Address

Above is the net worth, insider trading, and ownership report for Dmitry Kobyzev. Based on the public information released on the U.S. Securities and Exchange Commission (SEC) website, Dmitry Kobyzev's mailing address is: Moscow 1z 123317.

Research Tools

All-In-One Screener Stock Ideas Stock List Guru List Guru Real-Time Picks Insider List Insider Trades Economic Indicators Sector & Industry Performance DCF Calculator Discussion Board

Product

Pricing Plans Excel Add-In Google Sheets Add-on Data API Stock Comparison Table Manual of Stocks Instant Alerts Mobile App 中文

Education

Financial Glossary Tutorials FAQ Schedule Free Session Buffett Indicator Shiller P/E Yield Curve Today U.S. Inflation Rate Global Market Valuation Fed Net Liquidity Buffett Assets Allocation

Company

About GuruFocus Career Contact Us Advertise Term of Use Privacy Policy Referral Program Partner Program

Survey

We'd love to learn more about your experiences on GuruFocus.com and how we can improve!

Take Survey

Disclaimers

GuruFocus.com is not operated by a broker or a dealer. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes are provided by QuoteMedia, Inc. (CSI). Company fundamental data is provided by Morningstar. Analyst estimates data is sourced from both Refinitiv and Morningstar, with priority given to Refinitiv data. Data is updated daily.